From: Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population
 | All | IBD cases | Controls | p-value |  |  |
---|---|---|---|---|---|---|
N | 343 | 219 | 124 | Â | Â | Â |
Age (Mean ± SD) | 57.5 ± 12.5 | 34.0 ± 11.7 | 46.8 ± 9.9 | < 2.2e-16 |  |  |
Sex N (%) Male | 219 (63.8%) | 143 (65.2%) | 76 (61.2%) | 0.86 | Â | Â |
Type-2 Diabetes N (%) | Â | Â | Â | Â | Â | Â |
Yes N (%) | 8 (2.3%) | 8 (3.6%) | 0 (0%) | 0.013 | Â | Â |
Borderline N (%) | 6 (1.7%) | 6 (2.7%) | 0 (0%) | Â | Â | |
Family history N (%) | 16 (4.6%) | 16 (7.3%) | NA | -- | Â | Â |
Diagnosis | Â | Â | Â | Â | Â | Â |
Crohn’s N (%) | 135 (39.3%) | 135 (61.6%) | NA | -- |  |  |
Ulcerative N (%) | 84 (24.4%) | 84 (38.3%) | NA | Â | Â | |
Normal N (%) | 124 (36.1%) | NA | 124 (100.0%) | Â | Â | |
HbA1c (%) Median [IQR] | 5.7 [5.1,6.1] | 5.7 [5.1,6.1] | NA | -- | Â | Â |
CRP Median [IQR] | 1.2 [0.3,3] | 1.2 [0.3,3] | NA | -- | Â | Â |